![Nirupama Subramanian](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nirupama Subramanian
Directeur des opérations chez Rheos Medicines, Inc.
Provenance du réseau au premier degré de Nirupama Subramanian
Entité | Type d'entité | Industrie | |
---|---|---|---|
Orbital Therapeutics, Inc.
![]() Orbital Therapeutics, Inc. BiotechnologyHealth Technology Orbital Therapeutics, Inc. is a company based in Cambridge, MA that aims to enhance health by utilizing RNA-based medicines to treat human diseases in innovative ways. The company is building a platform that combines RNA technology delivery methods, data science, and automation to develop a portfolio of medicines focused on vaccines, immunomodulation, protein replacement, and regenerative medicine. The company was founded by Drew Weissman, John M. Maraganore, Kristina M. Burow, Ravindra Majeti, Giuseppe Ciaramella, Eugene W. Yeo, Howard Y. Chang, and Carol Suh, with Giuseppe Ciaramella serving as the CEO since incorporation.
11
| Holding Company | Biotechnology | 11 |
Rheos Medicines, Inc.
![]() Rheos Medicines, Inc. BiotechnologyHealth Technology Rheos Medicines, Inc. operates as a biopharmaceutical firm. It develops novel medicines that modulate metabolic pathways in immune cells to treat disease. The company was founded by Erika Pearce, Edward Pearce, Laurence Turka, Richard Flavell, Ken Smith, and E. William St. Clair and is headquartered in Cambridge, MA.
6
| Private Company | Biotechnology | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Nirupama Subramanian via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
ARCH Venture Partners LLC
![]() ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Analyst Private Equity Investor | |
BEAM THERAPEUTICS INC. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer President | |
Yale University | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
The University of California, San Francisco | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Chief Operating Officer Corporate Officer/Principal | |
Third Rock Ventures LLC
![]() Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor Private Equity Investor Private Equity Investor | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Rome Therapeutics, Inc.
![]() Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Founder | |
VIR BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Founder | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Operating Officer | |
University of Pennsylvania | College/University | Doctorate Degree Graduate Degree | |
JOUNCE THERAPEUTICS, INC. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
Third Rock Ventures GP LP | Corporate Officer/Principal Corporate Officer/Principal | ||
NEUMORA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
Biogen MA, Inc.
![]() Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Pretzel Therapeutics, Inc.
![]() Pretzel Therapeutics, Inc. BiotechnologyHealth Technology Pretzel Therapeutics, Inc. is an American biotechnology company that develops therapies by utilizing mitochondrial biology. Pretzel Therapeutics is based in an undisclosed location and has research facilities in another undisclosed location. The company aims to develop treatments that address the genetic causes of mitochondrial dysfunction. The company was founded by academic experts in mitochondrial biology and is supported by a world-class investor syndicate. Jay Parrish has been the CEO of the company since 2021. | Biotechnology | Director/Board Member Chief Executive Officer | |
Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Undergraduate Degree | |
BIOGEN INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree | |
University of California San Diego | College/University | Undergraduate Degree Corporate Officer/Principal | |
NEON THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
The Pfeffer Group LLC | Founder | ||
INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Public Communications Contact | |
McKinsey & Co., Inc.
![]() McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Bryn Mawr College | College/University | Undergraduate Degree | |
University of Maryland Medical System Corp.
![]() University of Maryland Medical System Corp. Hospital/Nursing ManagementHealth Services University of Maryland Medical System Corp. provides health care system. Its services include University of Maryland health advantage plan, University of Maryland quality care network, University of Maryland cancer network and diabetes network. The firm offers referral center for trauma, cancer care, neurocare, cardiac care, women's and children's health and physical rehabilitation. The company was founded in 1984 and is headquartered in Baltimore, MD. | Hospital/Nursing Management | Corporate Officer/Principal | |
VERVE THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
PRIME MEDICINE, INC. | Biotechnology | Director/Board Member | |
ImmuLogic Pharmaceutical Corp.
![]() ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Blink Therapeutics, Inc.
![]() Blink Therapeutics, Inc. BiotechnologyHealth Technology Part of Beam Therapeutics, Inc., Blink Therapeutics, Inc. develops a novel platform to generate therapeutic and diagnostic monoclonal antibodies. The company is based in Wilmington, DE. The CEO of the company is John Evans. | Biotechnology | Chief Executive Officer | |
Recovery Pharmaceuticals, Inc. | Founder | ||
Avaxia Biologics, Inc.
![]() Avaxia Biologics, Inc. BiotechnologyHealth Technology Avaxia Biologics, Inc. operated as a clinical-stage biotechnology company. It engaged in the development of gut-targeted antibody therapeutics for gastroenterology indications. Gut-targeted antibody therapeutics is orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal (GI) tract including the mouth, throat, and intestines. The company was founded by David Poorvin and Barbara S. Fox in 2005 and was headquartered in Lexington, MA. | Biotechnology | Founder | |
Auron Therapeutics, Inc.
![]() Auron Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Auron Therapeutics, Inc. operates as a biotechnology company. It aims to cure cancer by radically changing the paradigm of cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells. The company was founded by Kate Yen, Matt Vander Heiden, Ross Levine, and Eytan Stein and is headquartered in Wellesley, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Tango Therapeutics Sub, Inc.
![]() Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing | |
Unitio, Inc.
![]() Unitio, Inc. Internet Software/ServicesTechnology Services Unitio, Inc. operates a platform for the healthcare industry. | Internet Software/Services | Director/Board Member | |
Protein Technologies, Inc.
![]() Protein Technologies, Inc. Medical SpecialtiesHealth Technology Protein Technologies, Inc. engages in the design, manufacture and supply of solid phase synthesizers. The company was founded in 1985 and is headquartered in Tucson, AZ. | Medical Specialties | Corporate Officer/Principal | |
Cedilla Therapeutics, Inc.
![]() Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | Biotechnology | Chairman | |
Abata Therapeutics, Inc.
![]() Abata Therapeutics, Inc. BiotechnologyHealth Technology Abata Therapeutics, Inc. is a biotech company based in Watertown, MA. Abata Therapeutics is focused on developing engineered Treg cell therapies for severe autoimmune and inflammatory diseases. The American company's lead programs are in ind-enabling studies for progressive multiple sclerosis and type 1 diabetes, both of which are tissue-specific autoimmune diseases with significant unmet needs. The company has developed a differentiated product engine to create tissue-specific, robust, and durable therapies. Abata Therapeutics was launched by Third Rock Ventures, with participation from a diverse syndicate of investors, including ElevateBio, Lightspeed Venture Partners, Invus, Samsara Biocapital, and the JDRF T1D Fund. The company was founded in 2021 by Richard Ransohoff and the CEO is Samantha Singer. | Biotechnology | Chairman | |
Flare Therapeutics, Inc.
![]() Flare Therapeutics, Inc. BiotechnologyHealth Technology Flare Therapeutics is a biotechnology company that focuses on drugging transcription factors to develop small molecule medicines. The company is based in Cambridge, MA. The company's integrated discovery engine converges genetic, biochemical, and chemical insights to reveal druggable pockets and identify small molecule ligands capable of modulating transcription factors of high therapeutic potential. Flare's proteomic and mass spectrometry platform is powered by a proprietary library of electrophilic compounds unique to the company. The team has rapidly established an emerging pipeline of programs, highlighted by FX-909, a first-in-class investigational orally bioavailable small molecule inhibitor of PPARG, a master regulator of the luminal lineage in advanced urothelial cancer that has entered the clinic. Flare Therapeutics was launched in 2021 and is backed by founding investor Third Rock Ventures, as well as Boxer Capital, Nextech Invest, Casdin Capital, Invus Financial Advisors, and Eventide Asset Management. The company was founded by Mitchell Lazar, Fraydoon Rastinejad, Robert J. Sims, and Steven L. McKnight. Amit Rakhit has been the CEO of the company since 2022. | Biotechnology | Chairman |
Statistiques
Internationale
Etats-Unis | 51 |
Sectorielle
Health Technology | 28 |
Consumer Services | 10 |
Commercial Services | 7 |
Finance | 4 |
Health Services | 2 |
Opérationnelle
Director/Board Member | 119 |
Corporate Officer/Principal | 48 |
Founder | 29 |
Independent Dir/Board Member | 29 |
Chairman | 21 |
Relations les plus connectées
Insiders | |
---|---|
Kristina Burow | 43 |
John Maraganore | 38 |
Stephen Sherwin | 26 |
Abbie Celniker | 23 |
Cary Pfeffer | 18 |
Eugene Yeo | 17 |
John Duncan Higgons | 12 |
John Evans | 12 |
Jay Parrish | 11 |
Carol Suh | 11 |
John C. Davis | 10 |
Barbara Fox | 9 |
Giuseppe Ciaramella | 9 |
Ravindra Majeti | 8 |
Howard Y. Chang | 4 |
- Bourse
- Insiders
- Nirupama Subramanian
- Connexions Sociétés